Products and Services

French device company Biocorp has announced the launch of its Inspair sensor, which it says is “capable of converting any pressurized metered dose inhaler into a connected device.” According to the company, the sensor works… Read more . . .

California-based simulation and modeling software company Simulations Plus has announced that it will join the SimInhale COST (European Cooperation in Science and Technology) Action consortium, which aims to “advance particle designs for improved deposition and… Read more . . .

Capsugel has announced that it will add both pilot and commercial scale micronization capacity at a facility in Quakertown, PA which it acquired as part of its acquisition of Powdersize in January 2016. New equipment… Read more . . .

Bepak parent company Consort Medical has announced a multi-year agreement with AstraZeneca to supply Bespak’s MDI valves and actuators for use in AstraZeneca’s Bevespi Aerosphere inhaler. The components for the project, which will be called… Read more . . .

Particle characterization specialist Gateway Analytical will move to a new 17,000 sq ft (1,580 sq m) laboratory and office space in Gibsonia, Pennsylvania on September 1, 2016, according to an announcement by its parent company,… Read more . . .

Molex, which describes itself as “a global manufacturer of complete interconnect solutions,” will acquire device developer and manufacturer Phillips-Medisize from Golden Gate Capital, the company said. The financial terms of were not disclosed. Phillips-Medisize was… Read more . . .

Inhaler component manufacturer H&T Presspart has announced the opening of a new sales office in Montevideo, Uruguay to serve customers in the South and Central American region. In addition, Jesus Polanco, formerly Business Development Manager… Read more . . .

Adherium has announced that AstraZeneca will use Adherium’s SmartTouch Symbicort device in an upcoming 12-month clinical study of adherence in patients with COPD that is expected to enroll almost 400 US COPD patients. In July… Read more . . .

In its annual report for the fiscal year ended 30 April 2016, Consort Medical reports that its subsidiary Bespak experienced revenue growth of almost 11%, and CDMO Aesica, which Consort acquired in November 2014, experienced… Read more . . .